AstraZeneca and the federal government are awaiting the federal district court in Delaware's decision in the company’s 340B contract pharmacy lawsuit.

AstraZeneca and Feds Keep Sparring over 340B While Waiting for Judge to Rule

Drug manufacturer’s AstraZeneca and the federal government continue to joust in court as they await a crucial decision in the company’s 340B contract pharmacy lawsuit.

The two sides on Friday filed a joint status report in Astra’s lawsuit to invalidate and set aside the government’s May 17 finding that the company’s denials of 340B pricing when contract pharmacies are involved result in overcharges and violate the 340B statute. Astra and the government both have asked U.S. District Judge Leonard Stark of the District of Delaware to expedite his decision.

Drug manufacturer’s AstraZeneca and the federal government continue to joust in court as they await a crucial decision in the company’s 340B contract pharmacy lawsuit.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report